Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Feosol

(Ferrous sulfate)

ApprovedSmall molecule

AAuerbach Hematology Oncology Associates P C

Ferrous sulfate is used to treat iron deficiency anemia, a condition where your body doesn't have enough iron to make healthy red blood cells that carry oxygen throughout your body.[2] Feosol is currently approved and in use across 25 indications[4].[1]

Feosol is one of 547 small molecule programs targeting Premature Birth. It is currently in Approved.

25

Indications

63

Total Trials

13

Active Trials

546

Competitors

Pipeline

Status by Indication[4][1]

Indication

Premature BirthActive, not recruiting

Cardiovascular DiseaseActive, not recruiting

Cerebral PalsyActive, not recruiting

Hip FractureActive, not recruiting

Friedreich AtaxiaActive, not recruiting

AgeActive, not recruiting

Retinopathy of PrematurityActive, not recruiting

Movement DisorderActive, not recruiting

Iron Deficiency AnemiaUnknown

Infective EndocarditisActive, not recruiting

Premature BirthPreclinical

Active, not recruiting

Cardiovascular DiseasePreclinical

Active, not recruiting

Cerebral PalsyApproved

Active, not recruiting

Hip FracturePhase 3

Active, not recruiting

Friedreich AtaxiaPhase 1

Active, not recruiting

AgePreclinical

Active, not recruiting

Retinopathy of PrematurityPreclinical

Active, not recruiting

Movement DisorderApproved

Active, not recruiting

Iron Deficiency AnemiaPreclinical

Unknown

Infective EndocarditisPreclinical

Active, not recruiting

Showing 10 of 24 indications

Competition

Competitive Landscape

687 competitors in Heart Failure

#DrugCompanyPhaseTrials

Feosol

AAuerbach Hematology Oncology Associates P C

Medrol

LCZ696

Monoferric

PPharmacosmos A/S

Zemplar

Activase

Xifaxan

Tamiflu

CConrado Roberto Hoffmann Filho

Oraverse

LLife Extension Foundation Inc.

Neo-Synephrine

EExela Pharma Sciences, LLC.

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Post-ApprovalRecruiting

Iron Deficiency Anemia

NCT04278651

Phase 2Active, not recruiting

Chronic Kidney Disease

NCT05544513

Post-ApprovalNot yet recruiting

Iron Deficiency Anemia

NCT07414199

Q1 2027

Post-ApprovalNot yet recruiting

Musculoskeletal

NCT05708170

Post-ApprovalRecruiting

Heart Failure

NCT07053475

Phase 3Recruiting

Pregnancy

NCT05462704

Clinical

Trials by Indication[1]

Iron deficiency anemia16 trials

Early Antenatal Support for Iron Deficiency Anemia

Recruiting·TThomas Jefferson University·Phase 4·NCT04278651·80 enrolled

The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department

Not yet recruiting·—·Phase 4·NCT07414199·150 enrolled

Intravenous (IV) Versus Oral Iron Treatment of Iron Deficiency Anemia in the Post-operative Bariatric Surgical Patient

Withdrawn·JJohns Hopkins University·N/A·NCT03777514

Show 13 more trials

Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in Pregnancy

Terminated·TThe University of Texas Medical Branch, Galveston·Phase 4·NCT04594070·14 enrolled

Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients

Recruiting·AArooj Khan·N/A·NCT06742528·198 enrolled

Short Term Oral Iron Supplementation in Systolic Heart Failure Patients Suffering From Iron Deficiency Anemia

Completed·NNational Cardiovascular Center Harapan Kita Hospital Indonesia·Phase 2/3·NCT02998697·54 enrolled

Lactoferrin for Treatment of Iron Deficiency Anemia.

Completed·—·Phase 4·NCT04435574·90 enrolled

Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia

Recruiting·—·Phase 3·NCT06366698·900 enrolled

Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON)

Completed·UUniversity of Lagos, Nigeria·Phase 3·NCT04976179·1,056 enrolled

Lactoferrin Efficacy Versus Ferrous Sulfate in Treatment of Patients With Iron Deficiency Anemia

Completed·—·Phase 4·NCT04267653·96 enrolled

Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)

Completed·AAmerican Regent, Inc.·Phase 3·NCT00982007·997 enrolled

Daily vs. Every Other Day Oral Iron Supplementation in Patients With Absolute Iron Deficiency Anemia

Completed·SSunnybrook Health Sciences Centre·Phase 3·NCT03725384·51 enrolled

Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient

Recruiting·AAuerbach Hematology Oncology Associates P C·Phase 3·NCT04268849·104 enrolled

Iron Deficiency Anemia, Iron Supplementation and Genomic Stability in Infants

Unknown status·IInstituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri·Phase 4·NCT03359447·204 enrolled

Lactoferrin Versus Ferrous Sulfate in Management of Iron Deficiency Anemia Among Female Medical Ain Shams Students

Completed·Yyasmin gamal el gendy·Phase 2/3·NCT03940430·90 enrolled

Ferrous Acetyl-Aspartate Casein Formulation Evaluation Over Ferrous Sulfate in Iron Deficiency Anemia

Completed·UUni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.·Phase 4·NCT03524651·60 enrolled

Anemia9 trials

Treatment and Prevention of Anemia With Ferrous Sulfate Plus Folic Acid in Children in Goiania - Goias, Brazil

Completed·UUniversidade Federal de Goias·N/A·NCT00701246·196 enrolled

Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia

Completed·TThe University of Texas Medical Branch, Galveston·Phase 4·NCT05047211·40 enrolled

A Clinical Trial Assessing the Efficacy of Intravenous Iron for the Treatment of Anemia Following Cardiac Surgery

Completed·MMichael Kremke·Phase 4·NCT04608539·110 enrolled

Show 6 more trials

IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding

Unknown status·TThomas Jefferson University·Phase 4·NCT04205266·76 enrolled

Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia

Unknown status·PPeking Union Medical College Hospital·Phase 2·NCT03232554·180 enrolled

Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia

Completed·AAmerican Regent, Inc.·Phase 3·NCT00236977·182 enrolled

Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia

Terminated·NNorwegian University of Science and Technology·Phase 2/3·NCT00929409·30 enrolled

Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding

Completed·AAmerican Regent, Inc.·Phase 3·NCT00395993·456 enrolled

Comparison of Oral vs Intravenous Iron Therapy for the Treatment of Postpartum Anemia

Completed·SShahida Islam Medical Complex·N/A·NCT07340450·122 enrolled

Chronic Kidney Disease7 trials

Different Oral Iron Dosing Regimens in Treatment of Iron Deficency Anemia in Patients With Chronic Kidney Disease

Not yet recruiting·—··NCT06521216·150 enrolled

Oral Iron Supplementation for Patients With Chronic Kidney Disease

Active, not recruiting·UUniversidade Federal Fluminense·Phase 2·NCT05544513·6 enrolled

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents

Completed·WWatson Pharmaceuticals·Phase 4·NCT00224042·52 enrolled

Show 4 more trials

VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

Completed·AAmerican Regent, Inc.·Phase 3·NCT00317239·255 enrolled

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients

Completed·WWatson Pharmaceuticals·Phase 4·NCT00224055·89 enrolled

Oral Iron in Children With Chronic Kidney Disease

Recruiting·WWeill Medical College of Cornell University·Phase 4·NCT03991169·40 enrolled

A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease

Terminated·IIndiana University·Phase 4·NCT00830037·136 enrolled

Pregnancy4 trials

Lactoferrin Versus Ferrous Sulfate in Iron-deficiency During Pregnancy

Completed·—·Phase 2·NCT03759353·98 enrolled

Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial

Completed·IIndiana University·Phase 4·NCT03438227·38 enrolled

Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy

Recruiting·WWomen and Infants Hospital of Rhode Island·Phase 3·NCT05462704·300 enrolled

Show 1 more trial

Treatment of Non-Anemic Iron Deficiency in Pregnancy

Completed·SStony Brook University·N/A·NCT05423249·150 enrolled

Iron-deficiency3 trials

Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in Patients

Withdrawn·—·Phase 3·NCT04087993

Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency

Completed·UUniversity of Alabama at Birmingham·N/A·NCT02888171·60 enrolled

Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency

Completed·PProf. Dr. Frank Behrens·Phase 3·NCT03817957·187 enrolled

23 more indications

Safety and Efficacy2 trials

Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients

Completed·AAmerican Regent, Inc.·Phase 3·NCT00354484·291 enrolled

Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years

Completed·SShield Therapeutics·Phase 3·NCT05126901·65 enrolled

Critical Illness1 trial

Efficacy of Enteral Iron Supplementation in Critical Illness

Completed·WWeill Medical College of Cornell University·Phase 2·NCT00450177·200 enrolled

Adolescent1 trial

Alternate Day Versus Daily Oral Iron Therapy in Adolescents

Completed·—·Phase 4·NCT05007899·13 enrolled

Infants1 trial

Iron Supplementation of Lead-exposed Infants

Completed·—·Phase 2·NCT00374790·50 enrolled

Pediatric Patients1 trial

Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA

Completed·AAmerican Regent, Inc.·Phase 3·NCT03523117·79 enrolled

Tics1 trial

Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548

Completed·AAkebia Therapeutics·Phase 1·NCT02327546·10 enrolled

Heart Failure1 trial

IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches

Recruiting·SSyed Hamza Mufarrih·Phase 4·NCT07053475·250 enrolled

Lymphadenitis1 trial

Steroids vs Placebo in Treatment of Tuberculous Lymphadenitis

Completed·UUnknown Sponsor·N/A·NCT06236152·140 enrolled

Pilot Study1 trial

Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)

Completed·AAuerbach Hematology Oncology Associates P C·Phase 2·NCT02499354·100 enrolled

Absorption1 trial

Assessment of Iron Absorption From Aspergillus Oryzae

Completed·—·N/A·NCT03156725·16 enrolled

Pregnant Women1 trial

Once Versus Twice Daily Iron Supplementation in Pregnant Women

Terminated·UUniversity of Missouri-Columbia·N/A·NCT02839096·20 enrolled

Helicobacter Pylori Eradication1 trial

Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children

Completed·TThe University of Texas Health Science Center, Houston·Phase 3·NCT00364104·125 enrolled

Musculoskeletal1 trial

Impact of Intravenous Iron on Musculoskeletal Function in Older Adults

Not yet recruiting·LLiverpool Hope University·Phase 4·NCT05708170·100 enrolled

Cystic Fibrosis1 trial

Does a Daily Iron Tablet Improve Anemia in Cystic Fibrosis

Completed·—·N/A·NCT01755455·22 enrolled

Pediatric1 trial

IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD

Withdrawn·WWayne State University·Phase 2·NCT01438372

Inflammatory Bowel Disease1 trial

Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass

Completed·AAmerican Regent, Inc.·Phase 4·NCT02086968·198 enrolled

Hypoxia1 trial

Impact of Iron Supplementation on Right Ventricular Function and Exercise Performance in Hypoxia

Not yet recruiting·UUniversity of Colorado, Denver·Phase 1·NCT05349630·5 enrolled

Cerebral Palsy1 trial

Comparison of Twice Weekly Versus Daily Iron Therapy in Treating Anemia in Children With Cerebral Palsy

Unknown status·SShaheed Zulfiqar Ali Bhutto Medical University·Phase 4·NCT06176430·160 enrolled

Autism Spectrum Disorder1 trial

Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder

Completed·UUniversity of Colorado, Denver·Phase 2·NCT01745497·24 enrolled

Children1 trial

Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD)

Completed·—·Phase 3·NCT04371536·1 enrolled

Movement Disorder1 trial

Oral Iron Frequency for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder

Terminated·MMayo Clinic·Phase 4·NCT04610827·6 enrolled

Peritoneal Dialysis1 trial

Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study

Recruiting·HHull University Teaching Hospitals NHS Trust·Phase 3·NCT06884280·30 enrolled

Pregnancy Related1 trial

Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia

Completed·SStanford University·Phase 3·NCT04253626·83 enrolled

Sources

References

[1]
ClinicalTrials.gov — 63 trial records for Ferrous sulfate. U.S. National Library of Medicine, National Institutes of Health.
[2]
MedlinePlus Drug Information — Feosol drug information. U.S. National Library of Medicine, National Institutes of Health.
[3]
ChEMBL — Ferrous sulfate compound record. European Bioinformatics Institute (EMBL-EBI).
[4]
Open Targets Platform — Drug–disease associations for Ferrous sulfate. EMBL-EBI & Wellcome Sanger Institute.
[5]
SEC EDGAR — Auerbach Hematology Oncology Associates P C company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[3]
Highest Phase: Approved[1]
Company: AAuerbach Hematology Oncology Associates P C

Related News